http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-658596-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 |
| filingDate | 1978-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3547afe915926c7a7e6d7646147fdbc |
| publicationDate | 1986-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CH-658596-A5 |
| titleOfInvention | Immunoglobulin preparation suitable for intravenous administration |
| abstract | The immunoglobulin preparation which is suitable for intravenous administration causes no detectable antigen-independent activation of the complement factor C1 on intravenous administration and virtually no complement consumption in an in vitro haemolysis test. It contains essentially unchanged 7-S immunoglobulin with a molecular weight which is essentially unchanged from the 7-S fraction contained in the immunoglobulin. It displays essentially undiminished antibody but reduced antigen-independent complement activity and only few complement-binding structures and is accordingly also capable of only little antigen-independent binding of complement. |
| priorityDate | 1976-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.